241 related articles for article (PubMed ID: 18022360)
1. Smac mimetics and TNFalpha: a dangerous liaison?
Wu H; Tschopp J; Lin SC
Cell; 2007 Nov; 131(4):655-8. PubMed ID: 18022360
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
4. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
Vince JE; Wong WW; Khan N; Feltham R; Chau D; Ahmed AU; Benetatos CA; Chunduru SK; Condon SM; McKinlay M; Brink R; Leverkus M; Tergaonkar V; Schneider P; Callus BA; Koentgen F; Vaux DL; Silke J
Cell; 2007 Nov; 131(4):682-93. PubMed ID: 18022363
[TBL] [Abstract][Full Text] [Related]
5. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
Petersen SL; Peyton M; Minna JD; Wang X
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11936-41. PubMed ID: 20547836
[TBL] [Abstract][Full Text] [Related]
6. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
7. CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex.
Maas C; Tromp JM; van Laar J; Thijssen R; Elias JA; Malara A; Krippner-Heidenreich A; Silke J; van Oers MH; Eldering E
Cell Death Dis; 2013 Aug; 4(8):e782. PubMed ID: 23990022
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule SMAC mimetics as new cancer therapeutics.
Bai L; Smith DC; Wang S
Pharmacol Ther; 2014 Oct; 144(1):82-95. PubMed ID: 24841289
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists.
Beug ST; Conrad DP; Alain T; Korneluk RG; Lacasse EC
Int J Dev Biol; 2015; 59(1-3):141-7. PubMed ID: 26374535
[TBL] [Abstract][Full Text] [Related]
10. SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner.
Greer RM; Peyton M; Larsen JE; Girard L; Xie Y; Gazdar AF; Harran P; Wang L; Brekken RA; Wang X; Minna JD
Cancer Res; 2011 Dec; 71(24):7640-8. PubMed ID: 22049529
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Derakhshan A; Chen Z; Van Waes C
Clin Cancer Res; 2017 Mar; 23(6):1379-1387. PubMed ID: 28039268
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
14. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
[TBL] [Abstract][Full Text] [Related]
16. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
17. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
Li L; Thomas RM; Suzuki H; De Brabander JK; Wang X; Harran PG
Science; 2004 Sep; 305(5689):1471-4. PubMed ID: 15353805
[TBL] [Abstract][Full Text] [Related]
18. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
19. An apoptosis-independent role of SMAC in tumor suppression.
Qiu W; Liu H; Sebastini A; Sun Q; Wang H; Zhang L; Yu J
Oncogene; 2013 May; 32(19):2380-9. PubMed ID: 22751125
[TBL] [Abstract][Full Text] [Related]
20. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK
Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
